220 related articles for article (PubMed ID: 20170971)
21. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
22. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.
Andreassen CN; Alsner J; Overgaard M; Overgaard J
Radiother Oncol; 2003 Nov; 69(2):127-35. PubMed ID: 14643949
[TBL] [Abstract][Full Text] [Related]
23. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer.
Andreassen CN; Alsner J; Overgaard J; Herskind C; Haviland J; Owen R; Homewood J; Bliss J; Yarnold J
Radiother Oncol; 2005 Apr; 75(1):18-21. PubMed ID: 15878096
[TBL] [Abstract][Full Text] [Related]
24. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
[TBL] [Abstract][Full Text] [Related]
25. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
26. Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery.
Terrazzino S; La Mattina P; Masini L; Caltavuturo T; Gambaro G; Canonico PL; Genazzani AA; Krengli M
Radiother Oncol; 2012 May; 103(2):199-205. PubMed ID: 22248507
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
28. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).
Güven M; Unal M; Batar B; Eroğlu E; Devarnoğlu K; Tamçelik N; Uçar D; Sarici A
Mol Vis; 2007 Jan; 13():12-7. PubMed ID: 17242676
[TBL] [Abstract][Full Text] [Related]
31. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.
Liu B; Wei J; Zou Z; Qian X; Nakamura T; Zhang W; Ding Y; Feng J; Yu L
Eur J Hum Genet; 2007 Oct; 15(10):1049-53. PubMed ID: 17593927
[TBL] [Abstract][Full Text] [Related]
33. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
35. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
[TBL] [Abstract][Full Text] [Related]
36. Association between DNA repair gene ATM polymorphisms and oral cancer susceptibility.
Bau DT; Chang CH; Tsai MH; Chiu CF; Tsou YA; Wang RF; Tsai CW; Tsai RY
Laryngoscope; 2010 Dec; 120(12):2417-22. PubMed ID: 21108427
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
38. Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma.
Baris S; Celkan T; Batar B; Guven M; Ozdil M; Ozkan A; Apak H; Yildiz I
Pediatr Hematol Oncol; 2009 Sep; 26(6):467-72. PubMed ID: 19657998
[TBL] [Abstract][Full Text] [Related]
39. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
[TBL] [Abstract][Full Text] [Related]
40. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
